WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Lucy Mutuo Ngutu and Deus Oendo*

ABSTRACT

Depo Provera is an injection for women that contain progestin hormone, given as an intramuscular injection for every 3months. It prevents pregnancy mainly by suppressing ovulation, thickening cervical mucus preventing sperm from passing through it and by thinning the endometrium preventing implantation. An estimated 16.5million women are using Depo Provera worldwide. Globally the use of Depo Provera has risen from 54% to 57.4%.The main objective for the study was to determine utilization of Depo Provera among women of reproductive age attending MCH/FP clinic at Mwingi Level IV hospital. A cross-sectional hospital-based design was used. The area of study was Mwingi Level IV Hospital. Included women of reproductive age 18-45 years who consented for participation. Convenience sampling method was employed and a sample of 50 subjects was selected. Data collection was by a questionnaire and was analyzed using Microsoft excel and SPSS Version 21. Descriptive statistics computed included frequencies, proportions and percentages. Those with secondary and tertiary level,56%were most likely to utilize Depo Provera due to their educational level.50% of the respondents had their information from service providers while others had their information from spouse and friends.60%of the respondents chose the facility due to quality services offered there. 90% said that health care providers counselled and health educate them concerning the DMPA at the facility.78%said that the health care providers were friendly when giving services. Knowledge and institutional factors were found to majorly affect Depo Provera utilization. The study concluded that women of reproductive age had knowledge towards Depo Provera hence the high utilization. Institutional factors were found to be majorly associated with Depo Provera utilization.

[Full Text Article] [Download Certificate]